IBDEI0UF ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,13548,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13548,1,3,0)
 ;;=3^Shock,Cardiogenic
 ;;^UTILITY(U,$J,358.3,13548,1,4,0)
 ;;=4^R57.0
 ;;^UTILITY(U,$J,358.3,13548,2)
 ;;=^5019525
 ;;^UTILITY(U,$J,358.3,13549,0)
 ;;=R57.1^^83^812^77
 ;;^UTILITY(U,$J,358.3,13549,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13549,1,3,0)
 ;;=3^Shock,Hypovolemic
 ;;^UTILITY(U,$J,358.3,13549,1,4,0)
 ;;=4^R57.1
 ;;^UTILITY(U,$J,358.3,13549,2)
 ;;=^60845
 ;;^UTILITY(U,$J,358.3,13550,0)
 ;;=R57.9^^83^812^78
 ;;^UTILITY(U,$J,358.3,13550,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13550,1,3,0)
 ;;=3^Shock,Unspec
 ;;^UTILITY(U,$J,358.3,13550,1,4,0)
 ;;=4^R57.9
 ;;^UTILITY(U,$J,358.3,13550,2)
 ;;=^5019527
 ;;^UTILITY(U,$J,358.3,13551,0)
 ;;=R55.^^83^812^79
 ;;^UTILITY(U,$J,358.3,13551,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13551,1,3,0)
 ;;=3^Syncope and Collapse
 ;;^UTILITY(U,$J,358.3,13551,1,4,0)
 ;;=4^R55.
 ;;^UTILITY(U,$J,358.3,13551,2)
 ;;=^116707
 ;;^UTILITY(U,$J,358.3,13552,0)
 ;;=I78.0^^83^812^80
 ;;^UTILITY(U,$J,358.3,13552,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13552,1,3,0)
 ;;=3^Telangiectasia,Hereditary Hemorrhagic
 ;;^UTILITY(U,$J,358.3,13552,1,4,0)
 ;;=4^I78.0
 ;;^UTILITY(U,$J,358.3,13552,2)
 ;;=^117566
 ;;^UTILITY(U,$J,358.3,13553,0)
 ;;=I73.1^^83^812^20
 ;;^UTILITY(U,$J,358.3,13553,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13553,1,3,0)
 ;;=3^Buerger's Disease
 ;;^UTILITY(U,$J,358.3,13553,1,4,0)
 ;;=4^I73.1
 ;;^UTILITY(U,$J,358.3,13553,2)
 ;;=^5007798
 ;;^UTILITY(U,$J,358.3,13554,0)
 ;;=G45.9^^83^812^81
 ;;^UTILITY(U,$J,358.3,13554,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13554,1,3,0)
 ;;=3^Transient Cerebral Ischemic Attack,Unspec
 ;;^UTILITY(U,$J,358.3,13554,1,4,0)
 ;;=4^G45.9
 ;;^UTILITY(U,$J,358.3,13554,2)
 ;;=^5003959
 ;;^UTILITY(U,$J,358.3,13555,0)
 ;;=G45.8^^83^812^82
 ;;^UTILITY(U,$J,358.3,13555,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13555,1,3,0)
 ;;=3^Transient Cerebral Ischemic Attacks & Related Syndromes
 ;;^UTILITY(U,$J,358.3,13555,1,4,0)
 ;;=4^G45.8
 ;;^UTILITY(U,$J,358.3,13555,2)
 ;;=^5003958
 ;;^UTILITY(U,$J,358.3,13556,0)
 ;;=I83.019^^83^812^85
 ;;^UTILITY(U,$J,358.3,13556,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13556,1,3,0)
 ;;=3^Varicose Veins Right Lower Extrem w/ Ulcer Unspec Site
 ;;^UTILITY(U,$J,358.3,13556,1,4,0)
 ;;=4^I83.019
 ;;^UTILITY(U,$J,358.3,13556,2)
 ;;=^5007979
 ;;^UTILITY(U,$J,358.3,13557,0)
 ;;=I83.899^^83^812^83
 ;;^UTILITY(U,$J,358.3,13557,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13557,1,3,0)
 ;;=3^Varicose Veins Lower Extrem w/ Other Complications
 ;;^UTILITY(U,$J,358.3,13557,1,4,0)
 ;;=4^I83.899
 ;;^UTILITY(U,$J,358.3,13557,2)
 ;;=^5008018
 ;;^UTILITY(U,$J,358.3,13558,0)
 ;;=I83.90^^83^812^84
 ;;^UTILITY(U,$J,358.3,13558,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13558,1,3,0)
 ;;=3^Varicose Veins Lower Extrem,Asymptomatic
 ;;^UTILITY(U,$J,358.3,13558,1,4,0)
 ;;=4^I83.90
 ;;^UTILITY(U,$J,358.3,13558,2)
 ;;=^5008019
 ;;^UTILITY(U,$J,358.3,13559,0)
 ;;=I87.2^^83^812^86
 ;;^UTILITY(U,$J,358.3,13559,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13559,1,3,0)
 ;;=3^Venous Insufficiency
 ;;^UTILITY(U,$J,358.3,13559,1,4,0)
 ;;=4^I87.2
 ;;^UTILITY(U,$J,358.3,13559,2)
 ;;=^5008047
 ;;^UTILITY(U,$J,358.3,13560,0)
 ;;=E78.01^^83^812^32
 ;;^UTILITY(U,$J,358.3,13560,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13560,1,3,0)
 ;;=3^Familial Hypercholesterolemia
